Streamlined Genetic Education and Cascade Testing in Men from Hereditary Breast Ovarian Cancer Families: A Randomized Trial.
Humans
Male
Genetic Testing
/ methods
Female
Middle Aged
Genetic Counseling
/ methods
Adult
BRCA2 Protein
/ genetics
Genetic Predisposition to Disease
BRCA1 Protein
/ genetics
Ovarian Neoplasms
/ genetics
Mutation
Patient Education as Topic
/ methods
Aged
Hereditary Breast and Ovarian Cancer Syndrome
/ genetics
BRCA1
BRCA2
Cascade testing
Genetic counseling
Genetic testing
Prostate cancer risk
Traceback testing
Journal
Public health genomics
ISSN: 1662-8063
Titre abrégé: Public Health Genomics
Pays: Switzerland
ID NLM: 101474167
Informations de publication
Date de publication:
2024
2024
Historique:
received:
11
03
2024
accepted:
18
07
2024
medline:
23
8
2024
pubmed:
23
8
2024
entrez:
22
8
2024
Statut:
ppublish
Résumé
When a pathogenic BRCA1 or BRCA2 mutation is identified in a family, cascade genetic testing of family members is recommended since the results may inform screening or treatment decisions in men and women. However, rates of cascade testing are low, and men are considerably less likely than women to pursue cascade testing. To facilitate cascade testing in men, we designed a Web-based genetic education tool that addressed barriers to cascade testing, was individually tailored, delivered proactively, and could be used in lieu of pretest genetic counseling to streamline the cascade testing process. We randomized 63 untested men from hereditary cancer families to Web-based genetic education (WGE) versus enhanced usual care (EUC). WGE participants were provided access to a genetic education website after which they could accept or decline genetic testing or opt for pretest genetic counseling. EUC participants received an informational brochure and a letter informing them of their eligibility for genetic testing and recommending they schedule genetic counseling. The primary outcome was the uptake of genetic testing. Men in the WGE group were more likely to complete genetic counseling and/or genetic testing (43% vs. 12.1%; χ2 [n = 63, df = 1] = 7.77, p = 0.005). WGE participants were also more likely to complete genetic testing compared to men in the EUC group (30% vs. 9.1%; χ2 [n = 63, df = 1] = 4.46, p = 0.03). This preliminary trial suggests that a streamlined approach to genetic testing using proactively delivered genetic education may reduce barriers to cascade testing for at-risk men, leading to increased uptake. These results should be interpreted cautiously given the select sample and high rate of non-response.
Identifiants
pubmed: 39173603
pii: 000540466
doi: 10.1159/000540466
doi:
Substances chimiques
BRCA2 Protein
0
BRCA1 Protein
0
BRCA2 protein, human
0
BRCA1 protein, human
0
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
100-109Informations de copyright
© 2024 The Author(s). Published by S. Karger AG, Basel.